Found 25 matching trials
Docetaxel, Doxorubicin (A), Cyclophosphamide (C) (TAC) vs 5-Fluorouracil, A, C (5FAC) Breast Cancer Adjuvant Treatment PHASE3 This is a prospective, non-blinded randomized phase III trial. Patients wil...
Show More Location
Spanish Breast Cancer Research Group
Learn More & Join Trial
Triptorelin in Preventing Early Menopause in Premenopausal Women Who Are Receiving Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By Surgery PHASE3 RATIONALE: Chemotherapy may cause early menopause in premenopausal women. T...
Show More Learn More & Join Trial
ACHP-THP vs EC-THP as Neoadjuvant Therapy for HER2-positive EBC PHASE2 Breast cancer is the most common malignant tumor in women. EC-TH is one of ...
Show More Status
Active Not Recruiting
Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
Six vs 12 Months of Trastuzumab With Docetaxel Following FEC as Adjuvant Treatment in N+ Breast Cancer PHASE3 This trial will compare 6 versus 12 months of trastuzumab in combination wi...
Show More Location
University Hospital of Crete
Learn More & Join Trial
Localized High-Risk Soft Tissue Sarcomas Of The Extremities And Trunk Wall In Adults: An Integrating Approach Comprising Standard Vs Histotype-Tailored Neoadjuvant Chemotherapy PHASE3 This is a randomized Phase III clinical trial in the setting of localized h...
Show More Location
Fondazione Del Piemonte Per L'Oncologia Ircc Di Candiolo -
Learn More & Join Trial
Partial Irradiation and Sequential vs. Concurrent Chemo Early Breast Cancer NA In a small study at Johns Hopkins, women were treated with partial breast i...
Show More Status
Active Not Recruiting
Location
Sibley Memorial Hospital
Learn More & Join Trial
Trastuzumab Versus Lapatinib as Neoadjuvant Treatment for Her2+ Patients PHASE2 Phase II randomized multicenter trial to compare Epirubicin and Cyclophosph...
Show More Location
Hospital Germans Trias i Pujol
Learn More & Join Trial
Neoadjuvant Study Chemotherapy vs Letrozole + Abemaciclib in HR+/HER2- High/Intermediate Risk Breast Cancer Patients PHASE2 Phase II, randomized, open-label, international, multicenter study to compa...
Show More Status
Active Not Recruiting
Location
Complejo Hospitalario Universitario de Santiago (CHUS)
Learn More & Join Trial
AC vs TC in Patients With HR-positive, HER2-negative Early Breast Cancer PHASE4 Anthracycline-paclitaxel sequential combination therapy is the standard reg...
Show More Location
Second Affiliated Hospital, School of Medicine, Zhejiang University, China
Learn More & Join Trial
Plinabulin iv Solution in Prevention of TAC Induced Neutropenia PHASE2 The primary purpose of this study is to compare the duration of severe neut...
Show More Location
Cancer Center of Guangzhou Medical University Breast Oncology
Learn More & Join Trial